Copy

Special Edition: Covid 19 Prevention, Prophylaxis and Treatment in Pregnancy

Letter from our MFMs

Covid-19 has impacted many communities in Nebraska, and the goal of this communication is to emphasize the importance of prioritizing maternal morbidity and mortality in our pregnant patients during this pandemic.   

Pregnant individuals are at increased risk of severe COVID-19 infection, with a 3-fold increased risk for ICU admission, 2.4-fold increased risk for needing ECMO, and 1.7-fold risk of death. These risks increase in those who are Hispanic/Latino, Black or have high-risk pregnancies such as those with BMI > 35, diabetes, and/or heart disease.   

In a recent joint statement representing experts in maternal care including the Society for Maternal-Fetal Medicine (SMFM),  American College of Obstetricians and Gynecologists (ACOG), American Academy of Family Physicians, American Academy of Phys, American Academy of Pediatrics, American Association of Nurse Practitioners, American College of Nurse-Midwives, and American College of Osteopathic Obstetricians & Gynecologists, vaccination is STRONGLY RECOMMENDED for all individuals who are planning pregnancy, or currently pregnant regardless of gestational age or lactating.  Over 200,000 women have been vaccinated with no increased risk of miscarriage, birth defects or pregnancy complications.  

Pregnant patients remain one of the least vaccinated populations in spite of the higher risk and recent recommendations. As a provider of maternity care, please talk to your patients and RECOMMEND VACCINATION FOR YOUR PREGNANT PATIENTS. It is safe, free and pregnant individuals should feel confident in choosing vaccination to protect themselves, their infants, their families, and their communities 

In the event of a COVID-19 positive pregnant patient, the SMFM also recommends that no therapies that would otherwise be given for COVID-19 should be withheld specifically due to pregnancy or lactation. This includes the provision of monoclonal antibodies (REGEN-COV), remdesivir, and dexamethasone to pregnant patients who qualify. If you have a patient that tests positive for Covid-19 (assuming she is symptomatic) or if an unvaccinated patient lives with someone who has Covid-19, please consider discussing monoclonal antibody therapy.  Monoclonal antibodies are indicated for mild to moderate disease (SaO2 > 94%) and for prophylactic treatment for patients at high risk of complications, for which all pregnant individuals are included. Once the patient needs supplemental oxygen therapy, monoclonal antibodies are no longer beneficial and inpatient management is likely necessary.  

If you have questions please contact one of the Maternal-fetal Medicine physicians in the state. 

For more information on the contents of this newsletter, contact pbrown@npqic.org 
Facebook
Website
Our mailing address is:
981205 Nebraska Medical Ctr., Omaha, Nebraska
You can update your preferences or unsubscribe from this list.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Nebraska Perinatal Quality Improvement Collaborative · 982145 Nebraska Medical Center · Omaha, NE 68198-2145 · USA

Email Marketing Powered by Mailchimp